Biodesix Corp - רווח נקי למניה (EPS TTM) BDSX

EPS dynamics, as reflected in the asset value chart, illustrate the efforts of Biodesix, Inc. (BDSX) to expand its B2B partner network and implement precision lung tests. However, slow adoption of these methods by insurance companies limits cash inflows, with the indicator standing at 49.30. High marketing expenses and competitive pressure create barriers to break-even, intensifying the risks of a prolonged operating deficit.
biodesix.com - פילוחים אנליטיים ומדדי מפתח (BDSX)

This indicator measures the dynamics of the rolling annual earnings per share, allowing for an assessment of net income scaling rates and cash flow sustainability. By analyzing the historical delta of eps YoY ttm, an investor can see how stable demand for Biodesix, Inc. biotechnologies shields the business from macroeconomic shocks, confirming the company's status as a reliable defensive asset.